Artemis Investment Management LLP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 220,334 shares of the medical research company’s stock, valued at approximately $13,069,000. Artemis Investment Management LLP owned approximately 0.07% of Agilent Technologies as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Parallel Advisors LLC increased its position in shares of Agilent Technologies by 5.3% in the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after buying an additional 131 shares in the last quarter. Trust Co. of Vermont increased its position in shares of Agilent Technologies by 8.1% in the first quarter. Trust Co. of Vermont now owns 2,743 shares of the medical research company’s stock valued at $145,000 after buying an additional 205 shares in the last quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC increased its position in shares of Agilent Technologies by 17.2% in the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock valued at $196,000 after buying an additional 486 shares in the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Agilent Technologies during the second quarter valued at about $200,000. Finally, ELM Advisors LLC acquired a new position in shares of Agilent Technologies during the second quarter valued at about $202,000.

Agilent Technologies, Inc. (NYSE A) opened at 64.38 on Friday. The company has a market cap of $20.73 billion, a PE ratio of 33.20 and a beta of 1.30. The firm has a 50 day moving average price of $61.25 and a 200 day moving average price of $57.11. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $65.18.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.09 billion. During the same period last year, the firm earned $0.49 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. On average, analysts anticipate that Agilent Technologies, Inc. will post $2.32 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Artemis Investment Management LLP Takes Position in Agilent Technologies, Inc. (A)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be viewed at https://www.watchlistnews.com/artemis-investment-management-llp-takes-position-in-agilent-technologies-inc-a/1537984.html.

Several brokerages have recently issued reports on A. Bank of America Corporation boosted their price objective on Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a research report on Wednesday, August 16th. Barclays PLC reiterated a “buy” rating and set a $67.00 price objective on shares of Agilent Technologies in a research report on Wednesday, July 19th. Wells Fargo & Company upgraded Agilent Technologies from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $42.92 to $60.73 in a research report on Wednesday, July 12th. Deutsche Bank AG reiterated a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a research report on Thursday, June 22nd. Finally, BidaskClub upgraded Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research report on Sunday, August 6th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $63.18.

In other Agilent Technologies news, Director Boon Hwee Koh sold 4,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total value of $286,335.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Didier Hirsch sold 72,545 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total transaction of $4,525,357.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 141,098 shares of company stock worth $8,798,933.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.